首页 | 本学科首页   官方微博 | 高级检索  
检索        

解剖性肝切除联合脾切除对肝癌合并肝硬化脾亢的应用研究
引用本文:祝青,杨雪芳.解剖性肝切除联合脾切除对肝癌合并肝硬化脾亢的应用研究[J].中国煤炭工业医学杂志,2011,14(12):1755-1757.
作者姓名:祝青  杨雪芳
作者单位:274031,山东省菏泽市立医院普外科
摘    要:目的探讨解剖性肝切除联合脾切除对肝癌合并门脉高压并脾亢患者的治疗价值,以期为临床诊疗工作提供理论支持。方法选取64例确诊为肝癌合并门脉高压并脾亢的患者,依随机的原则分为二组,观察组共32例,应用解剖性肝切除联合脾切除进行治疗,对照组共32例,应用传统的手术方法,观察相关临床特征的改变。结果二组患者均顺利完成手术,对血细胞症及肝功能的改善均明显,但观察组术后并发症的发生率明显低于对照组,观察组术后3年生存率明显高于对照组。结论解剖性肝切除联合脾切除对肝癌合并门脉高压并脾亢患者的疗效明显,并可以提高术后患者的生存率,临床治疗中可以应用。

关 键 词:肝切除  解剖性  脾切除  肝癌  门脉高压  脾亢

THE SURGICAL TREATMENT OF PRIMARY HEPATOCELLULAR CARCINOMA WITH PORTAL HYPERTENSION AND HYPERSPLENISM BY ANATOMICAL LIVER RESECTION AND SPLENECTOMY
Zhu Qing , Yang Xuefang.THE SURGICAL TREATMENT OF PRIMARY HEPATOCELLULAR CARCINOMA WITH PORTAL HYPERTENSION AND HYPERSPLENISM BY ANATOMICAL LIVER RESECTION AND SPLENECTOMY[J].Chinese Journal of Coal Industry Medicine,2011,14(12):1755-1757.
Authors:Zhu Qing  Yang Xuefang
Institution:Zhu Qing,Yang Xuefang.General Surgery,Heze Municipal Hospital,Heze 274031,China
Abstract:Objective To observe the curative effect in patients with primary hepatocellular carcinoma with portal hypertension and hypersplenism by anatomical liver resection and splenectomy,and to provide theoretical basis for directing clinical treatment.Methods 64 patients were divided into randomly two groups.The control group(32 cases) were treated by normal treatment,the observation group(32 cases) were treated by anatomical liver resection and splenectomy.The efficacy and the clinical characteristic of patients...
Keywords:anatomical liver resection  splenectomy  protal hypertension  hypersplenism  clinical effect  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号